Neural basis of anxiolytic effects of cannabidiol (CBD) in generalized social anxiety disorder: a preliminary report
José Alexandre S. Crippa(Conselho Nacional de Desenvolvimento Científico e Tecnológico), Jaime E. C. Hallak(Conselho Nacional de Desenvolvimento Científico e Tecnológico), Rocío Martín‐Santos(Conselho Nacional de Desenvolvimento Científico e Tecnológico), Geraldo F. Busatto(Universidade de São Paulo), Paolo Fusar‐Poli(South London and Maudsley NHS Foundation Trust), Zerrin Atakan(University of London), Lauro Wichert‐Ana(Center for Translational Molecular Medicine), Antônio Waldo Zuardi(Universidade de São Paulo), Thiago Borduqui Ferrari(Center for Neurosciences), Philip McGuire(Oxford Health NHS Foundation Trust), Maria Cecília Freitas-Ferrari(Center for Neurosciences), Marcus Vinı́cius Simões(Universidade de Ribeirão Preto), Alaor Santos Filho(Center for Neurosciences), Sagnik Bhattacharyya(University of London), Fábio Ls Duran(Universidade de São Paulo), Guilherme Nogueira Derenusson(Center for Neurosciences)
Cited by 530
Related Papers
Age at onset of mental disorders worldwide: large-scale meta-analysis of 192 epidemiological studies
|Molecular Psychiatry|2021|3.6k
Rapid antidepressant effects of the psychedelic ayahuasca in treatment-resistant depression: a randomized placebo-controlled trial
|Psychological Medicine|2018|819
Cannabidiol Reduces the Anxiety Induced by Simulated Public Speaking in Treatment-Naïve Social Phobia Patients
|Neuropsychopharmacology|2011|763
Cognitive impairment in schizophrenia: aetiology, pathophysiology, and treatment
|Molecular Psychiatry|2023|684
Impact of coronavirus syndromes on physical and mental health of health care workers: Systematic review and meta-analysis
|Journal of Affective Disorders|2020|659